Palvanil 是一种 Capsaicin (MS-R45786) 类似物,对 TRPV1 受体表现出较强的脱敏能力,具有抗疼痛和抗炎作用。
产品编号: MS-K17093 纯度: 98.01% CAS No.: 69693-13-6 分子式: C24H41NO3 分子量: 391.59
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
询价
50mg
询价
询价

产品描述

Palvanil 是一种 Capsaicin (MS-R45786) 类似物,对 TRPV1 受体表现出较强的脱敏能力,具有抗疼痛和抗炎作用。

生物实验数据

生物活性 Palvanil is a Capsaicin (MS-R45786) analog that exhibits strong desensitization of the TRPV1 receptor and possesses anti-pain and anti-inflammatory effects.
体外研究
(In Vitro)

Palvanil (0.1-1000 nM; 0-300 min) leads to calcium increasment in HEK-293 intracellular.
Palvanil (1-10 nM; 5 min) treatment desensitizes TRPV1 to the effect of Capsaicin significantly.

Cell Viability Assay

Cell Line: HEK-293 cells
Concentration: 0.1, 0.5, 1, 5, 10, 50, 100 and 1000 nM
Incubation Time: 0-300 min
Result: Produced a dose-dependent increase in intracellular calcium with a EC50 of 0.65 nM.

Cell Viability Assay

Cell Line: HEK-293-TPRV1 cells
Concentration: 1-10 nM
Incubation Time: 5 min
Result: Desensitized TRPV1 to the effect of Capsaicin significantly (IC50=0.81 nM).
体内研究
(In Vivo)

Palvanil (subcutaneous injection; 1 or 10 mg/kg; once) treatment shows hypothermic effect.
Palvanil (intraperitoneal injection; 100 μL (15 nM) per mouse; once) treatment reduces Capsaicin-induced bronchoconstriction.
Palvanil (intravenous injection; 0.5, 0.75, and 1 mg/kg; once) treatment shows antinociceptive effects on Formalin-induced nocifensive behavior.
Palvanil (intravenous injection; 0.5, 0.75, and 1 mg/kg; once) treatment inhibits Carrageenan-induced inflammation.
Palvanil (intravenous injection; 0.5 and 1 mg/kg; once daily; 7 days) reduces mechanical allodynia and thermal hyperalgesia in spared nerve injury (SNI) mice.

Animal Model: Male CD-1 mice
Dosage: 1 or 10 mg/kg
Administration: Subcutaneous injection; 1 or 10 mg/kg; once
Result: Led to a slight and short lasting hypothermic effect, produced late hyperthermia.
Animal Model: Female BALB/C mice
Dosage: 100 μL (15 nM) per mouse
Administration: Intraperitoneal injection; 100 μL (15 nM) per mouse; once
Result: Induced a significantly lower bronchoconstriction (from 0.47 to 0.605 cm H2O/L/s).
Animal Model: Male CD-1 mice received formalin
Dosage: 0.5, 0.75, and 1 mg/kg
Administration: Intravenous injection; 0.5, 0.75, and 1 mg/kg; once
Result: Reduced the second phase of Formalin-induced nociceptive behaviour in a dose-dependent manner.
Animal Model: Male C57BL/6J mice with acute inflammation induced by Carrageenan
Dosage: 2.5 mg/kg
Administration: Intravenous injection; 2.5 mg/kg; once
Result: Reduced the volume of the oedema in the ipsilateral hind paw (64%).
Animal Model: Male CD-1 mice
Dosage: 0.5 and 1 mg/kg
Administration: Intravenous injection; 0.5 and 1 mg/kg; once daily; 7 days
Result: Reduced mechanical allodynia and thermal hyperalgesia at 3 and 7 days after nerve injury in a dose-dependent manner.
性状 固体
颜色 White to off-white

化学信息

分子量 391.59
分子式 C24H41NO3
CAS No. 69693-13-6

储存&溶解度

储存方式
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 25 mg/mL (63.84 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM2.5537 mL12.7685 mL25.5369 mL63.8423 mL
5 mM0.5107 mL2.5537 mL5.1074 mL12.7685 mL
10 mM0.2554 mL1.2768 mL2.5537 mL6.3842 mL
15 mM0.1702 mL0.8512 mL1.7025 mL4.2562 mL
20 mM0.1277 mL0.6384 mL1.2768 mL3.1921 mL
25 mM0.1021 mL0.5107 mL1.0215 mL2.5537 mL
30 mM0.0851 mL0.4256 mL0.8512 mL2.1281 mL
40 mM0.0638 mL0.3192 mL0.6384 mL1.5961 mL
50 mM0.0511 mL0.2554 mL0.5107 mL1.2768 mL
60 mM0.0426 mL0.2128 mL0.4256 mL1.0640 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础